Anti-MDA5 antibody is significantly associated with interstitial lung disease, rapidly progressing interstitial lung disease, worse pulmonary outcome, and survival in US classic DM and CADM patients. PubMed, Arthritis Care Res (Hoboken), 09/28/2015. (Also see Myopathy and Myositis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.